featured
Efficacy of Intravenous Ferric Derisomaltose in Patients With Heart Failure and Iron Deficiency
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Lancet 2022 Nov 04;[EPub Ahead of Print], PR Kalra, JGF Cleland, MC Petrie, EA Thomson, PA Kalra, IB Squire, FZ Ahmed, A Al-Mohammad, PJ Cowburn, PWX Foley, FJ Graham, AG Japp, RE Lane, NN Lang, AJ Ludman, IC Macdougall, P Pellicori, R Ray, M Robertson, A Seed, I FordFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.